Viper Energy Stock (NASDAQ:VNOM), Trade Ideas

Viper Energy

Viper Energy Partners

Viper Energy Inc is focused on owning and acquiring mineral and royalty interests in oil and natural gas properties primarily in the Permian Basin. The Permian Basin is known to have a number of zones of oil and natural gas-bearing rock throughout.

Wall Street

News

Short Ideas

Pre-Market Outlook

Markets

Trading Ideas

VNOM

Top 3 Energy Stocks That May Crash This Quarter

Long Ideas

Dividends

Price Target

Analyst Ratings

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a  high dividend payout. 

Wall Street&#39;s Most Accurate Analysts Say Buy These 3 Energy Stocks With Over 3% Dividend Yields

Offerings

Movers

Viper Energy Inc (NASDAQ: VNOM) shares are trading lower Tuesday after the company announced a secondary offering.

What&#39;s Going On With Viper Energy Stock?

Viper Energy, Inc. - Class A Common Stock

Viper Energy Inc

<p>As of April 24, 2024, three stocks in the energy sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.</p>
<p>The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.  </p>
<p>Here's the latest list of major overbought players in this sector.</p>
<h3 class="wp-block-heading"><strong>Viper Energy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VNOM#NASDAQ">VNOM</a>)</strong></h3>
<ul>
<li>On April 19, Piper Sandler analyst Mark Lear maintained Viper Energy with an Overweight and raised the price target from $36 to $43. The company's stock gained around 5% over the past month and has a <a href="https://www.benzinga.com/quote/VNOM">52-week high of $41.22</a>.</li>
<li><strong>RSI Value:</strong> 73.72&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li><strong>VNOM Price Action:</strong> Shares of Viper Energy gained 2.2% to close at $39.98 on Tuesday.</li>
</ul>
<h3 class="wp-block-heading"><strong>Antero Resources Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AR#NYSE">AR</a>)</strong></h3>
<ul>
<li>On April 17, Morgan Stanley analyst Devin McDermott upgraded Antero Resources from Equal-Weight to Overweight and raised the price target from $26 to $36. The company's stock gained around 13% over the past month and <a href="https://www.benzinga.com/quote/AR">has a 52-week high</a> of $31.41.</li>
<li><strong>RSI Value:</strong> 72.21</li>
<li><strong>AR Price Action:</strong> Shares of Antero Resources gained 2.1% to close at $31.02 on Tuesday.</li>
</ul>
<h3 class="wp-block-heading"><strong>Pioneer Natural Resources Company</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PXD#NYSE">PXD</a>)</h3>
<ul>
<li>On April 23, Stifel analyst Derrick Whitfield maintained Pioneer Natural Resources with a Hold and raised the price target from $237 to $275. The company's stock gained around 3% over the past five days and has a <a href="https://www.benzinga.com/quote/PXD">52-week high</a> of $278.83.</li>
<li><strong>RSI Value:</strong> 71.55</li>
<li><strong>PXD Price Action:</strong> Shares of Pioneer Natural Resources gained 0.6% to close at $275.23 on Tuesday.</li>
</ul>
<p><strong>Also Read This</strong>: <a href="https://www.benzinga.com/news/earnings/24/04/38396305/tesla-boeing-and-3-stocks-to-watch-heading-into-wednesday">Tesla, Boeing And 3 Stocks To Watch Heading Into Wednesday</a></p>


<p>Piper Sandler  analyst Mark Lear   maintains Viper Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VNOM#NASDAQ">VNOM</a>) with a Overweight and raises the price target from $36 to $43.</p>


Piper Sandler Maintains Overweight on Viper Energy, Raises Price Target to $43

<p>Viper Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VNOM#NASDAQ">VNOM</a>) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.</p>
<p>The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>In the assessment of 12-month price targets, analysts unveil insights for Viper Energy, presenting an average target of $42.25, a high estimate of $52.00, and a low estimate of $36.00. This current average has increased by 3.88% from the previous average price target of $40.67. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1712772013_0.png" alt="price target chart" /></p>
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
<p>In examining recent analyst actions, we gain insights into how financial experts perceive Viper Energy. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Betty Jiang</td>
<td>Barclays</td>
<td>Announces</td>
<td>Overweight</td>
<td>$44.00</td>
<td>-</td>
</tr>
<tr>
<td>Neal Dingmann</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$52.00</td>
<td>$47.00</td>
</tr>
<tr>
<td>John Freeman</td>
<td>Raymond James</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$37.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Mark Lear</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$36.00</td>
<td>$37.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Viper Energy. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Viper Energy compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts predict movements in price targets, offering estimates for Viper Energy's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<p>Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Viper Energy's market standing. Stay informed and make well-considered decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/VNOM/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Viper Energy analyst ratings.</strong></a></p>
<h2>About Viper Energy</h2>
<p>Viper Energy Inc is focused on owning and acquiring mineral and royalty interests in oil and natural gas properties primarily in the Permian Basin. The Permian Basin is known to have a number of zones of oil and natural gas-bearing rock throughout.</p>
<h3>Viper Energy: Delving into Financials</h3>
<p><strong>Market Capitalization Analysis:</strong> The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.</p>
<p><strong>Revenue Growth:</strong> Viper Energy's revenue growth over a period of 3 months has been noteworthy. As of 31 December, 2023, the company achieved a revenue growth rate of approximately <strong>0.56%</strong>. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Energy sector.</p>
<p><strong>Net Margin:</strong> Viper Energy's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>27.83%</strong> net margin, the company effectively manages costs and achieves strong profitability.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of <strong>6.59%,</strong> the company showcases effective utilization of equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Viper Energy's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of <strong>1.6%,</strong> the company may face hurdles in achieving optimal financial returns.</p>
<p><strong>Debt Management:</strong> Viper Energy's debt-to-equity ratio is notably higher than the industry average. With a ratio of <b>1.07</b>, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.</p>
<h2>What Are Analyst Ratings?</h2>
<p>Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.</p>
<p>Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Breaking Down Viper Energy: 4 Analysts Share Their Views

<p>Barclays  analyst Betty Jiang   initiates coverage on Viper Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VNOM#NASDAQ">VNOM</a>) with a Overweight rating and announces Price Target of $44.</p>


Initiation

Barclays Initiates Coverage On Viper Energy with Overweight Rating, Announces Price Target of $44

<p>Truist Securities  analyst Neal Dingmann   maintains Viper Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VNOM#NASDAQ">VNOM</a>) with a Buy and raises the price target from $47 to $52.</p>


Truist Securities Maintains Buy on Viper Energy, Raises Price Target to $52

<p><strong>Viper Energy's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VNOM#NYSE">VNOM</a>) short percent of float has fallen 6.83% since its last report. The company recently reported that it has <strong>2.95 million shares sold short</strong>, which is 4.5% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 6.08 days to cover their short positions on average.</strong></p>
<h3>Why Short Interest Matters</h3>
<p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<p><strong>See Also:</strong> <a href="https://www.benzinga.com/short-interest"><strong>List of the most shorted stocks</strong></a></p>
<h3>Viper Energy Short Interest Graph (3 Months)</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1710430211_0.png" alt="short_fig" /></p>
<p>As you can see from the chart above the percentage of shares that are sold short for Viper Energy has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.</p>
<h3>Comparing Viper Energy's Short Interest Against Its Peers</h3>
<p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<p>According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Viper Energy's peer group average for short interest as a percentage of float is 11.10%, which means the company has <strong>less</strong> short interest than most of its peers.</p>
<p>Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/"><strong>This post by Benzinga Money explains how you can profit from it.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>


Short Sellers

How Is The Market Feeling About Viper Energy?

<p>During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a <a href="https://www.benzinga.com/yield-investments"><em> high dividend payout. </em></a></p>
<p>Benzinga readers can review the latest analyst takes on&nbsp;their favorite stocks&nbsp;by visiting our&nbsp;<a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings&nbsp;</a>page. Traders can sort through Benzinga&#39;s extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie"><em> by analyst accuracy </em></a>.</p>
<p>Below are the ratings of the most accurate analysts for three high-yielding stocks in the energy sector.</p>
<h3><strong>Viper Energy, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vnom#NASDAQ">VNOM</a>)</h3>
<ul>
<li><strong>Dividend Yield:</strong> 5.17%</li>
<li><strong>Raymond James</strong> analyst John Freeman maintained an Outperform rating and cut the price target from $38 to $37 on Jan. 24, 2024. This analyst has an accuracy rate of 78%.</li>
<li><strong>Piper Sandler</strong> analyst Mark Lear maintained an Overweight rating and lowered the price target from $37 to $36 on Jan. 24, 2024. This analyst has an accuracy rate of 71%.</li>
<li><strong>Recent News:</strong> On March 6, Viper Energy announced the launch of a secondary common stock offering of 11,500,000 shares by Diamondback Energy.</li>
</ul>
<h3><strong>EOG Resources, Inc. </strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/eog#NYSE">EOG</a>)</h3>
<ul>
<li><strong>Dividend Yield:</strong> 3.07%</li>
<li><strong>Piper Sandler</strong> analyst Mark Lear maintained an Overweight rating and cut the price target from $153 to $141 on March 7, 2024. This analyst has an accuracy rate of 71%.</li>
<li><strong>Raymond James</strong> analyst John Freeman maintained a Strong Buy rating and cut the price target from $148 to $145 on Jan. 24, 2024. This analyst has an accuracy rate of 78%.</li>
<li><strong>Recent News:</strong> On Feb. 22, EOG Resources posted in-line quarterly earnings.</li>
</ul>
<h3><strong>APA Corporation </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apa#NASDAQ">APA</a>)</h3>
<ul>
<li><strong>Dividend Yield:</strong> 3.25%</li>
<li><strong>Raymond James</strong> analyst John Freeman maintained a Strong Buy rating and cut the price target from $61 to $44 on Jan. 5, 2024. This analyst has an accuracy rate of 78%.</li>
<li><strong>Wells Fargo</strong> analyst Roger Read maintained an Overweight rating and lowered the price target from $53 to $52 on Nov. 22, 2023. This analyst has an accuracy rate of 71%.</li>
<li><strong>Recent News:</strong> On Feb. 21, APA posted downbeat quarterly results.</li>
</ul>
<p>&nbsp;</p>
<p>Read More: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/03/37555716/insiders-buying-snowflake-and-2-other-stocks"><em> Insiders Buying Snowflake And 2 Other Stocks</em></a></p>


Wall Street's Most Accurate Analysts Say Buy These 3 Energy Stocks With Over 3% Dividend Yields

WIIM

Viper Energy shares are trading lower after the company announced the launch of a secondary common stock offering of 11,500,000 shares by Diamondback Energy.

<p>The gross proceeds from the sale of the shares by the Selling Stockholder will be approximately $402.5 million. Viper will not receive any proceeds from the sale of the shares by the Selling Stockholder. The Secondary Offering is expected to close on March 8, 2024, subject to customary closing conditions.</p>


Viper Energy Prices $402.5M Secondary Offering Of 11.5M Common Shares By Diamondback Energy

Viper Energy Launches Secondary Common Stock Offering Of 11,500,000 Shares By Diamondback Energy

<p>Friday marks the last chance for investors to receive the next  dividend payout from <strong>Viper Energy Partners</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VNOM#NASDAQ">VNOM</a>). </p>
<h3>What's Happening</h3>
<p>The company announced on Tuesday that it would pay shareholders a quarterly dividend of 27 cents per share. On Monday, Viper Energy Partners will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other words, the stock will likely open 27 cents lower than it would have opened on any other day.</p>
<p>In order to be eligible to receive a company's dividend, shareholders must own the stock prior to the ex-dividend date—in this case, Monday. Shareholders who own VNOM as of the end of Friday's session are eligible to receive the 27 cents dividend payout for every share that they own. </p>
<p>According to the company, this dividend will be paid out to shareholders on March 12, 2024. Investors will then be able to either reinvest those dividends back into the stock or use the payment in some other way. </p>
<p><a href="https://www.benzinga.com/quote/VNOM">Monitor live stock price updates for Viper Energy Partners on Benzinga.</a></p>


Friday Is Your Last Chance To Buy Viper Energy Partners Before The Dividend Payout

<p><strong>Viper Energy</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VNOM#NASDAQ">VNOM</a>) reported its Q4 earnings results on Tuesday, February 20, 2024 at 04:01 PM.</p>
<p>Here's what investors need to know about the announcement.</p>
<h3>Earnings</h3>
<p>Viper Energy beat estimated earnings by 17.54%, reporting an EPS of $0.67 versus an estimate of $0.57.</p>
<p>Revenue was up $1.09 million from the same period last year.</p>
<h3>Past Earnings Performance</h3>
<p>Last quarter the company beat on EPS by $0.69 which was followed by a 3.59% increase in the share price the next day.</p>
<p>Here's a look at Viper Energy's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2023</strong></th>
<th><strong>Q2 2023</strong></th>
<th><strong>Q1 2023</strong></th>
<th><strong>Q4 2022</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.41</td>
<td>0.21</td>
<td>0.41</td>
<td>0.41</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.10</td>
<td>0.47</td>
<td>0.53</td>
<td>0.28</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>183.17M</td>
<td>159.57M</td>
<td>169.17M</td>
<td>181.72M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>293.24M</td>
<td>160.79M</td>
<td>168.96M</td>
<td>203.62M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Viper Energy <a href="https://www.benzinga.com/quote/VNOM/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Earnings

Viper Energy: Q4 Earnings Insights

<p>Viper Energy Partners (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VNOM#NASDAQ">VNOM</a>) reported quarterly earnings of $0.74 per share which beat the analyst consensus estimate of $0.57 by 29.82 percent.</p>


Earnings Beats

Viper Energy Partners Q4 2023 Adj EPS $0.74 Beats $0.57 Estimate

ABCL

ADEA

ALLE

AMPL

ANDE

AROC

AVNS

AXSM

BTCY

BYON

CAMT

CMTG

CRNT

CSGP

DBRG

DFIN

ENLC

ENVX

ESRT

ETRN

EXPD

FANG

GATO

GMED

HALO

HCKT

ILPT

INST

JBGS

KEYS

LAND

LGIH

MATX

MFIN

MIDD

MTDR

MTTR

NXRT

PANW

QUAD

SEDG

SEVN

SKWD

SMMT

SPNS

SPNT

TCMD

TDOC

Earnings Scheduled For February 20, 2024

<p><strong>Viper Energy Partners</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VNOM#NASDAQ">VNOM</a>) is set to give its latest quarterly earnings report on Tuesday, 2024-02-20. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that Viper Energy Partners will report an <strong>earnings per share</strong> (EPS) of $0.57. </p>
<p>Viper Energy Partners bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Historical Earnings Performance</h3>
<p>Last quarter the company beat EPS by $0.69, which was followed by a 3.59% increase in the share price the next day.</p>
<p>Here's a look at Viper Energy Partners's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2023</strong></th>
<th><strong>Q2 2023</strong></th>
<th><strong>Q1 2023</strong></th>
<th><strong>Q4 2022</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.41</td>
<td>0.21</td>
<td>0.41</td>
<td>0.41</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.10</td>
<td>0.47</td>
<td>0.53</td>
<td>0.28</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>3.59%</td>
<td>5.9%</td>
<td>-3.51%</td>
<td>-0.64%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1708351308_0.png" alt="eps graph" /></p>
<h3>Stock Performance</h3>
<p>Shares of Viper Energy Partners were trading at $34.5 as of February 15. Over the last 52-week period, shares are up 19.96%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/VNOM/earnings"><strong>To track all earnings releases for Viper Energy Partners visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings Outlook For Viper Energy Partners

<p>Raymond James  analyst John Freeman   maintains Viper Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VNOM#NASDAQ">VNOM</a>) with a Outperform and lowers the price target from $38 to $37.</p>


Raymond James Maintains Outperform on Viper Energy, Lowers Price Target to $37

<p>Piper Sandler  analyst Mark Lear   maintains Viper Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VNOM#NASDAQ">VNOM</a>) with a Overweight and lowers the price target from $37 to $36.</p>


Piper Sandler Maintains Overweight on Viper Energy, Lowers Price Target to $36

<p>Evercore ISI Group  analyst Stephen Richardson   reinstates Viper Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VNOM#NASDAQ">VNOM</a>) with a Outperform and announces $37 price target.</p>


Evercore ISI Group Reinstates Outperform on Viper Energy, Announces $37 Price Target

<p><strong>Viper Energy&nbsp;Inc</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vnom#NASDAQ">VNOM</a>) shares are trading lower Tuesday after the company announced <a href="https://www.benzinga.com/pressreleases/23/11/g35767293/viper-energy-announces-pricing-of-secondary-common-stock-offering-by-certain-stockholders-and-conc">a secondary offering</a>.</p>
<p><strong>What Happened: </strong>Viper&nbsp;priced&nbsp;an <a href="https://www.benzinga.com/pressreleases/23/11/g35767293/viper-energy-announces-pricing-of-secondary-common-stock-offering-by-certain-stockholders-and-conc">underwritten public offering</a> of 9,018,760 shares&nbsp;by certain selling stockholders for&nbsp;gross proceeds of&nbsp;approximately&nbsp;$264 million. Viper Energy will not receive any of the proceeds from the offering.&nbsp;</p>
<p>Viper Energy also&nbsp;agreed to purchase&nbsp;1&nbsp;million shares from the underwriter&nbsp;being sold as part of the secondary offering.&nbsp;</p>
<p>Viper Energy owns and acquires mineral and royalty interests in oil and natural gas properties primarily in the Permian Basin.</p>
<p><em>See Also:&nbsp;<a href="https://www.benzinga.com/economics/macro-economic-events/23/11/35775608/us-inflation-eases-more-than-expected-in-october-cements-expectations-for-end-of-">US Inflation Eases More Than Expected In October, Cements Expectations For End Of Interest Rate Hikes</a></em></p>
<p><strong>VNOM Price Action:</strong> <a href="https://www.benzinga.com/quote/VNOM">Viper Energy shares</a> were down 4.54% at $29.86 at the time of publication, according to&nbsp;<a href="https://benzinga.grsm.io/gxjhpowx7zks">Benzinga Pro</a>.</p>
<p><em>Photo:&nbsp;<a href="https://pixabay.com/users/3844328-3844328/?utm_source=link-attribution&amp;utm_medium=referral&amp;utm_campaign=image&amp;utm_content=1863880">3844328</a>&nbsp;from Pixabay.</em></p>


What's Going On With Viper Energy Stock?

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>Hidden gems often remain undiscovered within the labyrinth of the stock market. Three stocks with massive upside stand out among the several alternatives as possible titans with significant upside potential. By mid-decade, these healthcare, industrial, and energy companies may realize their latent potential and reshape market dynamics.</p>



<p>These industries may derive significant change as the world economy changes due to technological breakthroughs, well-timed acquisitions, and ground-breaking inventions. While the second one&rsquo;s strong revenue growth indicates its potential for quick expansion, the first one&rsquo;s smart acquisitions align with its growth ambitions. The advancement of its clinical pipeline demonstrates the third one&rsquo;s dedication to transforming therapeutic treatments.</p>



<p>Read more to discover these sleeping giants&rsquo; unrealized potential. All stocks hold significant return potential, whether in the broad fields of energy exploration or the more complex domains of data processing and medicinal breakthroughs. Fast-forward to explore the nuances of these stocks, opening doors to profitable investing opportunities and laying the groundwork for a revolutionary change in a portfolio&rsquo;s returns.</p>



<h2>Viper Energy (VNOM)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/04/energy-stocks-1600-300x169.png" alt="Person holding the glowing world in their hands with icons with different types of energy. AI Recommended Energy Stocks in July"><div>Source: PopTika / Shutterstock</div></div><p><strong>Viper Energy </strong>(NASDAQ:<span><a href="https://investorplace.com/stock-quotes/vnom-stock-quote/"><strong>VNOM</strong></a></span>) has actively pursued strategic acquisitions that complement its expansion goals. A significant accomplishment is purchasing certain <a href="https://finance.yahoo.com/news/viper-energy-partners-lp-nasdaq-141043212.html" target="_blank">mineral and royalty interests</a>&nbsp;from Warwick Capital Partners and GRP Energy Capital affiliates in the fourth quarter of 2023. According to all pertinent financial measures, this transaction is accretive and provides a high-quality undeveloped inventory.</p>



<p>Notably, as part of its expansion goal, the company turned&nbsp;<a target="_blank" href="https://www.viperenergy.com/node/9761/pdf">246 total gross horizontal wells</a>&nbsp;on its land into production in Q4 2023. These purchases strengthen Viper Energy&rsquo;s portfolio of assets, which might lead to more income streams in the future and accelerate its growth.</p>



<p>Looking forward, Viper Energy has set average daily production estimates of<a target="_blank" href="https://finance.yahoo.com/news/viper-energy-partners-lp-nasdaq-141043212.html">&nbsp;25,000 to 25,500 barrels of oil per day (bo/d</a>) for the first quarter of 2024 and 25,500 to 27,500 bo/d for the entire year 2024. Moreover, the company anticipates substantial growth in 2024, with output in Q4 of that year may be at or above the upper end of the guideline range.</p>



<p>Overall, the eighth straight quarter of rising production per share occurred in the fourth quarter of 2023. Therefore, growth in output over time is a sign of Viper Energy&rsquo;s asset-base capitalization. Savvy investors are grabbing this and the next stocks with massive upside quick. </p>



<h2>Concentrix (CNXC)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/04/retail-shopping-1600-300x169.png" alt="Friends sit on a ledge with shopping bags after shopping retail stores. Retail Stocks to Buy"><div>Source: Rawpixel.com / Shutterstock</div></div><p><strong>Concentrix</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/cnxc-stock-quote/"><strong>CNXC</strong></a></span>) has shown strong revenue growth, a critical indicator of the company&rsquo;s potential for quick development. The corporation had sales of&nbsp;<a href="https://ir.concentrix.com/static-files/b6e5f2d5-0fa1-4e35-b212-a953f8955e11" target="_blank">$7,114.7 million</a>&nbsp;for the fiscal year 2023, a 12.5% year-over-year (YoY) increase from the year prior. The $4,230.8 million in sales for the fourth quarter, up 36.0% YoY, highlights this development trend even further. </p>



<p>Moreover, with Webhelp adding almost $574 million in the final two months of Q4, the integration greatly aided revenue growth. Notably, critical verticals, including retail, travel, e-commerce, banking, financial services, insurance, and healthcare, had especially&nbsp;<a href="https://finance.yahoo.com/news/concentrix-corporation-nasdaq-cnxc-q4-152555907.html" target="_blank">robust revenue growth</a>. This indicates the company&rsquo;s diverse income sources and capacity to leverage important industries.</p>



<p>Furthermore, the quarterly revenue growth rate above the yearly growth rate shows growing momentum. This indicates Concentrix&rsquo;s ability to seize market share and exploit new possibilities. Looking ahead, Concentrix is confident in maintaining momentum and sees growth possibilities, as seen by its&nbsp;<a href="https://finance.yahoo.com/news/concentrix-corporation-nasdaq-cnxc-q4-152555907.html" target="_blank">positive outlook</a>&nbsp;for the upcoming fiscal year 2024. Overall, the company&rsquo;s goals are to reduce debt, generate good cash flow, maintain sales growth, and enhance profits. This is one of the stocks with massive upside you can&rsquo;t afford to miss. </p>



<h2>Omeros (OMER)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/biotech1600molecule-300x169.jpg" alt="a representation of floating molecules"><div>Source: Shutterstock</div></div><p>Clinical pipeline progress for <strong>Omeros</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/omer-stock-quote/"><strong>OMER</strong></a></span>) is the primary basis for value increases. The company may resubmit its Biologics License Application (BLA) for narsoplimab. This focuses on the event of thrombotic microangiopathy (TA-TMA) associated with hematopoietic stem cell transplantation. To compare survival statistics, the company filed a statistical analysis plan. Hence, an FDA clearance decision is anticipated in the&nbsp;<a href="https://finance.yahoo.com/news/omeros-corporation-nasdaq-omer-q3-200101786.html" target="_blank">middle of 2024</a>.</p>



<p>Notably, the&nbsp;<a href="https://finance.yahoo.com/news/omeros-corporation-nasdaq-omer-q3-200101786.html" target="_blank">Phase 3 ARTEMIS-IGAN</a>&nbsp;study for IgA nephropathy has been halted. Here, further analysis is being conducted to gain practical knowledge for future renal clinical research. Furthermore, the emphasis on TA-TMA and other indications highlights Omeros&rsquo; dedication to expanding narsoplimab.</p>



<p>Additionally, a clinical program for complement three glomerulopathy (C3G) has been started. Enrollment in Phase 2 studies for&nbsp;<a href="https://investor.omeros.com/news-releases/news-release-details/omeros-corporation-reports-third-quarter-2023-financial-results" target="_blank">OMS906 in PNH patients</a>&nbsp;has also been completed. The abstract was approved for a podium presentation at the American Society of Hematology (<strong>ASH</strong>). Hence, this highlights the clinical importance and possible market uniqueness of OMS906 in treating PNH.</p>



<p>Lastly, Omeros and the National Institute on Drug Abuse (NIDA) are working together to develop OMS527, which may broaden the company&rsquo;s range of treatments. If you are lookinng for stocks with massive upside, grab this one. </p>



<p><em>On the date of publication, Yiannis Zourmpanos did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.</em></p>
<div><p>Yiannis Zourmpanos is the founder of Yiazou Capital Research, a stock-market research platform designed to elevate the due diligence process through in-depth business analysis.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT793992">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/02/wall-street-legend-issues-urgent-ai-code-red/?cid=MKT781156&amp;eid=MKT793990">&ldquo;America&rsquo;s Top Trader&rdquo; Issues A.I. Code Red: Act Now or Miss Out</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793999">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
<p>The post <a href="https://investorplace.com/2024/03/sleeping-giants-3-picks-with-massive-upside-by-mid-decade/">Sleeping Giants: 3 Picks With Massive Upside by Mid-Decade</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

Sleeping Giants: 3 Picks With Massive Upside by Mid-Decade

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>Hidden gems often remain undiscovered within the labyrinth of the stock market. Three stocks with massive upside stand out among the several alternatives as possible titans with significant upside potential. By mid-decade, these healthcare, industrial, and energy companies may realize their latent potential and reshape market dynamics.</p>



<p>These industries may derive significant change as the world economy changes due to technological breakthroughs, well-timed acquisitions, and ground-breaking inventions. While the second one&rsquo;s strong revenue growth indicates its potential for quick expansion, the first one&rsquo;s smart acquisitions align with its growth ambitions. The advancement of its clinical pipeline demonstrates the third one&rsquo;s dedication to transforming therapeutic treatments.</p>



<p>Read more to discover these sleeping giants&rsquo; unrealized potential. All stocks hold significant return potential, whether in the broad fields of energy exploration or the more complex domains of data processing and medicinal breakthroughs. Fast-forward to explore the nuances of these stocks, opening doors to profitable investing opportunities and laying the groundwork for a revolutionary change in a portfolio&rsquo;s returns.</p>



<h2>Viper Energy (VNOM)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/04/energy-stocks-1600-300x169.png" alt="Person holding the glowing world in their hands with icons with different types of energy. AI Recommended Energy Stocks in July"><div>Source: PopTika / Shutterstock</div></div><p><strong>Viper Energy </strong>(NASDAQ:<span><a href="https://investorplace.com/stock-quotes/vnom-stock-quote/"><strong>VNOM</strong></a></span>) has actively pursued strategic acquisitions that complement its expansion goals. A significant accomplishment is purchasing certain <a href="https://finance.yahoo.com/news/viper-energy-partners-lp-nasdaq-141043212.html" target="_blank">mineral and royalty interests</a>&nbsp;from Warwick Capital Partners and GRP Energy Capital affiliates in the fourth quarter of 2023. According to all pertinent financial measures, this transaction is accretive and provides a high-quality undeveloped inventory.</p>



<p>Notably, as part of its expansion goal, the company turned&nbsp;<a target="_blank" href="https://www.viperenergy.com/node/9761/pdf">246 total gross horizontal wells</a>&nbsp;on its land into production in Q4 2023. These purchases strengthen Viper Energy&rsquo;s portfolio of assets, which might lead to more income streams in the future and accelerate its growth.</p>



<p>Looking forward, Viper Energy has set average daily production estimates of<a target="_blank" href="https://finance.yahoo.com/news/viper-energy-partners-lp-nasdaq-141043212.html">&nbsp;25,000 to 25,500 barrels of oil per day (bo/d</a>) for the first quarter of 2024 and 25,500 to 27,500 bo/d for the entire year 2024. Moreover, the company anticipates substantial growth in 2024, with output in Q4 of that year may be at or above the upper end of the guideline range.</p>



<p>Overall, the eighth straight quarter of rising production per share occurred in the fourth quarter of 2023. Therefore, growth in output over time is a sign of Viper Energy&rsquo;s asset-base capitalization. Savvy investors are grabbing this and the next stocks with massive upside quick. </p>



<h2>Concentrix (CNXC)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/04/retail-shopping-1600-300x169.png" alt="Friends sit on a ledge with shopping bags after shopping retail stores. Retail Stocks to Buy"><div>Source: Rawpixel.com / Shutterstock</div></div><p><strong>Concentrix</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/cnxc-stock-quote/"><strong>CNXC</strong></a></span>) has shown strong revenue growth, a critical indicator of the company&rsquo;s potential for quick development. The corporation had sales of&nbsp;<a href="https://ir.concentrix.com/static-files/b6e5f2d5-0fa1-4e35-b212-a953f8955e11" target="_blank">$7,114.7 million</a>&nbsp;for the fiscal year 2023, a 12.5% year-over-year (YoY) increase from the year prior. The $4,230.8 million in sales for the fourth quarter, up 36.0% YoY, highlights this development trend even further. </p>



<p>Moreover, with Webhelp adding almost $574 million in the final two months of Q4, the integration greatly aided revenue growth. Notably, critical verticals, including retail, travel, e-commerce, banking, financial services, insurance, and healthcare, had especially&nbsp;<a href="https://finance.yahoo.com/news/concentrix-corporation-nasdaq-cnxc-q4-152555907.html" target="_blank">robust revenue growth</a>. This indicates the company&rsquo;s diverse income sources and capacity to leverage important industries.</p>



<p>Furthermore, the quarterly revenue growth rate above the yearly growth rate shows growing momentum. This indicates Concentrix&rsquo;s ability to seize market share and exploit new possibilities. Looking ahead, Concentrix is confident in maintaining momentum and sees growth possibilities, as seen by its&nbsp;<a href="https://finance.yahoo.com/news/concentrix-corporation-nasdaq-cnxc-q4-152555907.html" target="_blank">positive outlook</a>&nbsp;for the upcoming fiscal year 2024. Overall, the company&rsquo;s goals are to reduce debt, generate good cash flow, maintain sales growth, and enhance profits. This is one of the stocks with massive upside you can&rsquo;t afford to miss. </p>



<h2>Omeros (OMER)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/biotech1600molecule-300x169.jpg" alt="a representation of floating molecules"><div>Source: Shutterstock</div></div><p>Clinical pipeline progress for <strong>Omeros</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/omer-stock-quote/"><strong>OMER</strong></a></span>) is the primary basis for value increases. The company may resubmit its Biologics License Application (BLA) for narsoplimab. This focuses on the event of thrombotic microangiopathy (TA-TMA) associated with hematopoietic stem cell transplantation. To compare survival statistics, the company filed a statistical analysis plan. Hence, an FDA clearance decision is anticipated in the&nbsp;<a href="https://finance.yahoo.com/news/omeros-corporation-nasdaq-omer-q3-200101786.html" target="_blank">middle of 2024</a>.</p>



<p>Notably, the&nbsp;<a href="https://finance.yahoo.com/news/omeros-corporation-nasdaq-omer-q3-200101786.html" target="_blank">Phase 3 ARTEMIS-IGAN</a>&nbsp;study for IgA nephropathy has been halted. Here, further analysis is being conducted to gain practical knowledge for future renal clinical research. Furthermore, the emphasis on TA-TMA and other indications highlights Omeros&rsquo; dedication to expanding narsoplimab.</p>



<p>Additionally, a clinical program for complement three glomerulopathy (C3G) has been started. Enrollment in Phase 2 studies for&nbsp;<a href="https://investor.omeros.com/news-releases/news-release-details/omeros-corporation-reports-third-quarter-2023-financial-results" target="_blank">OMS906 in PNH patients</a>&nbsp;has also been completed. The abstract was approved for a podium presentation at the American Society of Hematology (<strong>ASH</strong>). Hence, this highlights the clinical importance and possible market uniqueness of OMS906 in treating PNH.</p>



<p>Lastly, Omeros and the National Institute on Drug Abuse (NIDA) are working together to develop OMS527, which may broaden the company&rsquo;s range of treatments. If you are lookinng for stocks with massive upside, grab this one. </p>



<p><em>On the date of publication, Yiannis Zourmpanos did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.</em></p>
<div><p>Yiannis Zourmpanos is the founder of Yiazou Capital Research, a stock-market research platform designed to elevate the due diligence process through in-depth business analysis.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
<p>The post <a href="https://investorplace.com/2024/03/sleeping-giants-3-picks-with-massive-upside-by-mid-decade/">Sleeping Giants: 3 Picks With Massive Upside by Mid-Decade</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

FEN: Impending ETF Conversion Makes This Fund A Good Short-Term Play

Sitio Royalties started with Underweight rating at Barclays as distribution yield lags

Sitio Royalties started with an Underweight rating at Barclays as distribution yield lags

Viper Energy: Upside Exposure To Oil Prices Should Boost Its 2024 Dividend

In a report released today, Mark Lear from Piper Sandler maintained a Buy rating on Viper Energy (VNOM – Research Report), with a price target of $...

Piper Sandler Reaffirms Their Buy Rating on Viper Energy (VNOM)

Bernzott Capital Advisors U.S. Small Cap Value Fund Q1 2024 Commentary

In a report released today, Betty Jiang from Barclays maintained a Buy rating on Viper Energy (VNOM – Research Report), with a price target of $44....

Barclays Sticks to Their Buy Rating for Viper Energy (VNOM)

AMLP

BSCV

CNXC

GNTX

LANC

MPLX

OMER

PLXS

Press Releases

Viper Energy Partners LP, a Subsidiary of Diamondback Energy, Inc., Announces Closing of GRP Acquisition

Viper Energy Partners LP, A Subsidiary Of Diamondback Energy, Inc., Reports Third Quarter 2023 Financial And Operating Results; Announces Filing For Conversion Into A Delaware Corporation

Viper Energy Launches Secondary Common Stock Offering By Certain Stockholders and Concurrent Stock Repurchase

Financing

Viper Energy Announces Pricing of Secondary Common Stock Offering by Certain Stockholders and Concurrent Stock Repurchase

Viper Energy, Inc., a Subsidiary of Diamondback Energy, Inc., Schedules Fourth Quarter 2023 Conference Call for February 21, 2024

Viper Energy, Inc., a Subsidiary of Diamondback Energy, Inc., Reports Fourth Quarter and Full Year 2023 Financial and Operating Results

Viper Energy Launches Secondary Common Stock Offering By Diamondback Energy, Inc.

Viper Energy Announces Pricing of Secondary Common Stock Offering by Diamondback Energy, Inc.

Viper Energy Announces Pricing of Secondary Common Stock Offering by Diamondback Energy, Inc. | VNOM Stock News

Viper Energy, Inc., a Subsidiary of Diamondback Energy, Inc., Schedules First Quarter 2024 Conference Call for May 1, 2024

Black Stone Minerals, L.P. Common units representing limited partner interests

Black Stone Minerals

Chord Energy

Civitas Resources

CNX Resources

California Resources Corporation Common Stock

California Resources

Crescent Energy Company Class A Common Stock

Crescent Energy

Comstock Resources

Dorchester Minerals, L.P. - Common Units Representing Limited Partnership Interests

Dorchester Minerals

Gulfport Energy Corporation Common Shares

Gulfport Energy

HighPeak Energy

Kosmos Energy

Kimbell Royalty Partners Common Units Representing Limited Partner Interests

Kimbell Royalty Partners

Magnolia Oil & Gas Corporation Class A Common Stock

Magnolia Oil & Gas

Mach Natural Resources LP Common Units representing Limited Partner Interests

Mach Natural Resources

Matador Resources

Murphy Oil

Northern Oil & Gas

Range Resources

Sabine Royalty

SM Energy

Sitio Royalties Corp. Class A Common Stock

Sitio Royalties

Southwestern Energy

Talos Energy

Vista Energy S.A.B. de C.V. American Depositary Shares, each representing one series A share, with no par value

Vista Energy

Vital Energy, Inc. Common Stock, par value $0.01 per share

Vital Energy

Piper Sandler

Barclays

Truist Securities

Raymond James

Evercore ISI Group